Correlation Between Boeing and Acorda Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Boeing and Acorda Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Boeing and Acorda Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between The Boeing and Acorda Therapeutics, you can compare the effects of market volatilities on Boeing and Acorda Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Boeing with a short position of Acorda Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Boeing and Acorda Therapeutics.

Diversification Opportunities for Boeing and Acorda Therapeutics

-0.55
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Boeing and Acorda is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding The Boeing and Acorda Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acorda Therapeutics and Boeing is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on The Boeing are associated (or correlated) with Acorda Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acorda Therapeutics has no effect on the direction of Boeing i.e., Boeing and Acorda Therapeutics go up and down completely randomly.

Pair Corralation between Boeing and Acorda Therapeutics

Allowing for the 90-day total investment horizon The Boeing is expected to under-perform the Acorda Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, The Boeing is 4.53 times less risky than Acorda Therapeutics. The stock trades about -0.02 of its potential returns per unit of risk. The Acorda Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  1,600  in Acorda Therapeutics on August 26, 2024 and sell it today you would earn a total of  20.00  from holding Acorda Therapeutics or generate 1.25% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy29.14%
ValuesDaily Returns

The Boeing  vs.  Acorda Therapeutics

 Performance 
       Timeline  
Boeing 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days The Boeing has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Acorda Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Acorda Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Acorda Therapeutics is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Boeing and Acorda Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Boeing and Acorda Therapeutics

The main advantage of trading using opposite Boeing and Acorda Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Boeing position performs unexpectedly, Acorda Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acorda Therapeutics will offset losses from the drop in Acorda Therapeutics' long position.
The idea behind The Boeing and Acorda Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Transaction History
View history of all your transactions and understand their impact on performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals